319 related articles for article (PubMed ID: 16491981)
21. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
Dolev Z
Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
[TBL] [Abstract][Full Text] [Related]
22. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
Cankurtaran ES; Ozalp E; Soygur H; Akbiyik DI; Turhan L; Alkis N
Support Care Cancer; 2008 Nov; 16(11):1291-8. PubMed ID: 18299900
[TBL] [Abstract][Full Text] [Related]
23. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
24. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
Kang RH; Choi MJ; Paik JW; Hahn SW; Lee MS
Int J Psychiatry Med; 2007; 37(3):315-29. PubMed ID: 18314859
[TBL] [Abstract][Full Text] [Related]
25. Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
Schittecatte M; Dumont F; Machowski R; Fontaine E; Cornil C; Mendlewicz J; Wilmotte J
Psychiatry Res; 2002 Jan; 109(1):1-8. PubMed ID: 11850045
[TBL] [Abstract][Full Text] [Related]
26. Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
Funaki K; Nakajima S; Suzuki T; Mimura M; Uchida H
J Clin Pharmacol; 2016 Sep; 56(9):1111-9. PubMed ID: 26813241
[TBL] [Abstract][Full Text] [Related]
27. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
Shen J; Moller HJ; Wang X; Chung SA; Shapiro GK; Li X; Shapiro CM
J Clin Psychiatry; 2009 Mar; 70(3):370-7. PubMed ID: 19192466
[TBL] [Abstract][Full Text] [Related]
28. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
29. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
30. Mirtazapine for depression in patients with human immunodeficiency virus.
Elliott AJ; Roy-Byrne PP
J Clin Psychopharmacol; 2000 Apr; 20(2):265-7. PubMed ID: 10770469
[No Abstract] [Full Text] [Related]
31. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Radhakishun FS; van den Bos J; van der Heijden BC; Roes KC; O'Hanlon JF
J Clin Psychopharmacol; 2000 Oct; 20(5):531-7. PubMed ID: 11001237
[TBL] [Abstract][Full Text] [Related]
32. Whether to increase or maintain dosage of mirtazapine in early nonimprovers with depression.
Ueno F; Nakajima S; Suzuki T; Abe T; Sato Y; Mimura M; Uchida H
J Clin Psychiatry; 2015 Apr; 76(4):434-9. PubMed ID: 25919835
[TBL] [Abstract][Full Text] [Related]
33. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
Kasper S; Montgomery SA; Möller HJ; van Oers HJ; Jan Schutte A; Vrijland P; van der Meulen EA
World J Biol Psychiatry; 2010 Feb; 11(1):36-44. PubMed ID: 20146649
[TBL] [Abstract][Full Text] [Related]
35. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
Moustgaard G
J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
[No Abstract] [Full Text] [Related]
36. Mirtazapine, in orodispersible form, for patients with preoperative psychological distress: A pilot study.
Chou WH; Lin FS; Lin CP; Lin WY; Yie JC; Sun WZ
Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):16-23. PubMed ID: 26873652
[TBL] [Abstract][Full Text] [Related]
37. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
[TBL] [Abstract][Full Text] [Related]
38. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ
J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476
[TBL] [Abstract][Full Text] [Related]
39. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
40. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
